Gene Signatures of T-Cell Activation Can Serve as Predictors of Functionality for SARS-CoV-2-Specific T-Cell Receptors.

SARS-CoV-2 TCRs TCR functionality prediction scRNA sequencing

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
27 Sep 2022
Historique:
received: 15 08 2022
revised: 15 09 2022
accepted: 23 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

The importance of T cells in controlling SARS-CoV-2 infections has been demonstrated widely, but insights into the quality of these responses are still limited due to technical challenges. Indeed, understanding the functionality of the T-cell receptor (TCR) repertoire of a polyclonal antigen-specific population still requires the tedious work of T-cell cloning or TCR re-expression and subsequent characterization. In this work, we show that it is possible to discriminate highly functional and bystander TCRs based on gene signatures of T-cell activation induced by recent peptide stimulation. SARS-CoV-2-specific TCRs previously identified by cytokine release after peptide restimulation and subsequent single-cell RNA sequencing were re-expressed via CRISPR-Cas9-mediated gene editing into a Jurkat-based reporter cell line system suitable for high-throughput screening. We could observe differences in SARS-CoV-2 epitope recognition as well as a wide range of functional avidities. By correlating these

Identifiants

pubmed: 36298482
pii: vaccines10101617
doi: 10.3390/vaccines10101617
pmc: PMC9611811
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : EIT Health CoViproteHCt
ID : 20877
Organisme : the German National Network of University Medicine of the Federal Ministry of Education and Research [BMBF; NaFoUniMedCovid19, COVIM],
ID : 01KX2021
Organisme : Deutsche Forschungsgesellschaft (DFG; German Research Foundation)
ID : SFB1321/1-329628492 [project P17]
Organisme : Deutsche Forschungsgesellschaft (DFG; German Research Foundation)
ID : SFB-TRR 338/1 2021-452881907 [project A01]

Références

Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2118312119
pubmed: 35561224
Cell Death Dis. 2017 Jun 1;8(6):e2836
pubmed: 28569770
Nature. 2022 Apr;604(7906):553-556
pubmed: 35240676
Nat Med. 2022 Mar;28(3):490-495
pubmed: 35046573
N Engl J Med. 1995 Oct 19;333(16):1038-44
pubmed: 7675046
Front Immunol. 2019 Nov 29;10:2820
pubmed: 31849987
Sci Rep. 2020 Oct 20;10(1):17832
pubmed: 33082362
PLoS Comput Biol. 2021 Mar 25;17(3):e1008814
pubmed: 33764977
Lancet. 2003 Oct 25;362(9393):1375-7
pubmed: 14585640
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32611686
Front Immunol. 2020 Aug 25;11:1803
pubmed: 32983088
Vaccine. 2016 Apr 12;34(17):2008-14
pubmed: 26954467
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Science. 2022 Jun 24;376(6600):eabq4411
pubmed: 35608440
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
J Biol Chem. 2010 Feb 19;285(8):5488-96
pubmed: 20028981
Transfusion. 2011 Mar;51(3):591-9
pubmed: 21133926
Arch Virol. 2009;154(7):1093-9
pubmed: 19526193
Cancer Res. 2007 Apr 15;67(8):3898-903
pubmed: 17440104
Nat Biomed Eng. 2019 Dec;3(12):974-984
pubmed: 31182835
Nat Biotechnol. 2020 Jan;38(1):44-49
pubmed: 31819258
J Immunol Methods. 2016 Mar;430:10-20
pubmed: 26780292
Nature. 2022 Feb;602(7898):654-656
pubmed: 35016196
J Virol. 2011 Oct;85(20):10464-71
pubmed: 21813600
STAR Protoc. 2021 Dec 14;3(1):101031
pubmed: 34977677
Nature. 2017 Jul 6;547(7661):94-98
pubmed: 28636589
Sci Immunol. 2022 Aug 12;7(74):eabm2077
pubmed: 35960818
Nat Med. 2021 Jan;27(1):78-85
pubmed: 33184509
Cell. 2022 Mar 3;185(5):847-859.e11
pubmed: 35139340
Clin Infect Dis. 2011 Jan 1;52(1):49-57
pubmed: 21148519
J Immunol. 2019 Apr 1;202(7):2164-2171
pubmed: 30760621
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Immunity. 2020 Dec 15;53(6):1258-1271.e5
pubmed: 33296686
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Front Immunol. 2019 Nov 06;10:2568
pubmed: 31781096
Cell Rep. 2022 Jan 11;38(2):110214
pubmed: 34968416
Cell Rep Med. 2021 Aug 17;2(8):100374
pubmed: 34467251
Commun Biol. 2020 Jul 24;3(1):394
pubmed: 32709928
Mol Syst Biol. 2020 Aug;16(8):e9416
pubmed: 32779888
N Engl J Med. 2022 Apr 21;386(16):1579-1580
pubmed: 35294809
Nature. 2022 Feb;602(7898):676-681
pubmed: 35016198
Nat Commun. 2022 Jul 18;13(1):4165
pubmed: 35851055
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Nat Med. 2022 Mar;28(3):472-476
pubmed: 35042228
Nat Commun. 2021 Jul 26;12(1):4515
pubmed: 34312385
Clin Transl Immunology. 2020 Nov 23;9(11):e1216
pubmed: 33251011
Nature. 2022 Feb;602(7895):148-155
pubmed: 34875673
J Exp Med. 2005 Apr 4;201(7):1053-9
pubmed: 15809350

Auteurs

Laura M Mateyka (LM)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.

Philipp M Strobl (PM)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.

Sebastian Jarosch (S)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.

Sebastian J C Scheu (SJC)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.

Dirk H Busch (DH)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 81675 Munich, Germany.

Elvira D'Ippolito (E)

Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich (TUM), 81675 Munich, Germany.

Classifications MeSH